Arabic Arabic English English French French German German
dark

Oncology Pharma, Inc. Is Pursuing the Development of Its Small Molecule Drug for the Treatment of Colon Cancer

Oncology Pharma Inc. (OTC PINK:ONPH) Oncology Pharma, Inc. is pursuing, through its licensing arrangements, the development of a small molecule drug for the treatment of colon cancer. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

OAG report into vaccine programme ‘useful and timely’ says Ministry

Next Post

Kelyniam Global Releases Q1 Financial Results – Profitability Despite the 2nd Wave Pandemic

Related Posts
Total
0
Share